Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
Special Article

An Innovative Proposal for the Health Care Financing System of the United States

Glenn E. Austin and Robert D. Burnett
Pediatrics May 2003, 111 (5) 1093-1097; DOI: https://doi.org/10.1542/peds.111.5.1093
Glenn E. Austin
*Beaverton, Oregon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert D. Burnett
‡Sunnyvale, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • Comments
Loading
Download PDF

With >40 million uninsured residents in the United States, we still spend more of our gross national product on health care than any other country in the world.1 Changes in the various health financing systems must occur if this problem is to be solved.2–4 A sound medical financing system that will meet the basic needs of the entire population requires efficient use of the medical dollar while ameliorating medical care inflation and encouraging innovation, productive competition, and progress toward quality cost-effective health care. Neither the current market-driven system nor the existing governmental quasi-National Health Insurance (NHI) Medicare and Medicaid programs meet these requirements.5–8 Single payer and nationalized health care in other countries suffer from under funding, long waiting lines, inadequate facilities, rigid regulations, and frequently lack of patient choice.9 We propose new and innovative reforms that require a Federal Health Insurance Reserve System (FHIRS) to reduce ingrained errors and enhance the positive aspects of both the market and government systems. Whatever system develops a FHIRS will be pertinent, be it our new market-driven proposal or a single payer or national health insurance systems.

PROBLEMS REQUIRING SOLUTIONS

  1. The uninsured and underinsured.

  2. Politically and litigiously mandated benefits.10–12

  3. Unequal tax treatment for health financing.

  4. Lack of individual choice of plans and providers.

  5. Perverse financial incentives for the insurance industry.13–17

  6. Underfunded and confused Medicaid programs.7,18

  7. The Ponzi-type Medicare scam of cross-generational financing.19–22.

  8. Insufficient national clinical trials and lack of constraint of unnecessary malpractice suits.4,23,24

  9. Unfair competition by hospitals charging their own patients different amounts for identical services and pharmaceutical companies charging individuals and small organizations more than large organizations, increasing the number of uninsured.

  10. Excessive costs threaten the national economy, access to quality medical services, and federal and state budgets partly because of the lack of economic incentives to limit health care expenditures.

  11. Lack of a national program to coordinate, analyze, and recommend optimizing medical care and controlling costs.

To correct these deficiencies, we propose that Congress create individual tax incentives, mandate universal catastrophic coverage, and charter an independent FHIRS protected from direct political, commercial, and legal pressures to establish regulatory controls and productive incentives for a competitive market-based system. FHIRS would be charged to encourage efficient use of health care dollars for the public good, increase freedom of individual choice coupled with acceptance of individual responsibility, ameliorate inflation, and stimulate innovative and fair competition. The most unique portion of this proposal is the enactment of FHIRS, which would be useful for either government or market-based systems.

HOW THE FHIRS PROPOSAL WOULD AMELIORATE THESE PROBLEMS

  1. The underinsured and uninsured:

    Congressional enactment of compulsory catastrophic health insurance for all residents and compulsory additional basic health insurance for all children and citizens under the 200% poverty level would bring all residents into a multifaceted health care system.

  2. Politically and litigiously mandated benefits:

    FHIRS would be isolated as much as possible from direct political, legal, and commercial pressures, as is the Federal Reserve System for banking, allowing it to collect outcome and cost data and use scientific analysis to develop tax-advantaged health insurance benefits and payment parameters. FHIRS would define the benefit packages for catastrophic insurance required for all and the more comprehensive basic insurance mandated for children and encouraged for the entire population. A federal subsidy would be used for those under the 200% poverty level and reverse-to-income tax credits for all others.

    Congress would estimate the cost to the budget from subsidy, tax credits, and loss of revenue from favorable tax treatment and direct FHIRS to limit tax-advantaged expenditures to a budgeted figure. It would not direct how the cuts should be made or cut or add specific benefits. Those would be developed by FHIRS on a scientific rather than a political basis. Which benefits will be the most beneficial to society remains to be seen and will become an ongoing FHIRS decision.

  3. Unequal tax treatment for health financing:

    The employer would no longer have deductions for the cost of health insurance but could provide employees with a defined contribution. Individuals could use a defined contribution, their own funds, and would receive a tax credit inversely related to income to purchase tax-free FHIRS defined policies. Any defined contribution not used to purchase approved FHIRS policies would be taxed at the usual rate for that individual.

  4. Lack of individual choice of plans and providers:

    Employers would no longer choose so insurance companies would offer the tax-advantaged policies to individuals and families while also offering taxable supplemental policies. FHIRS would approve the insurance companies’ disclosure statements to prospective purchasers identifying eligible providers if providers are limited, how they are paid, and the anticipated ratio of providers to patients as well as the clearly delineated benefits package and copayment requirements. Enrollment could take place at the workplace, many public offices, or with the individual’s federal income tax payment.

    Individuals could hire brokers, but broker fees would not be eligible for tax deductions or credits, whether the fees are included in the insurance premium or the individual pays the broker. Those receiving subsidies for payment could chose their own policies and would be subject to limited copayments.

  5. Perverse fiscal incentives for the insurance industry:

    The current economic incentive for insurers is to enroll healthy people. FHIRS would level the risk assumed by insurers to encourage fair competition. Each enrollee would submit a simple risk assessment questionnaire to be used to index their individual risk when purchasing a policy. These would be bar-coded and an average enrollee risk index established for each policy to compare with other insurer’s policies. FHIRS would transfer some of the premium from plans having lower average risk enrollees to plans with higher risk enrollees. Simple stratification of age/sex data clearly demonstrates risk.25–29 With actuarial assistance FHIRS could further refine a simple questionnaire with a few questions on family history or diagnosed conditions, significantly improving its accuracy. Although not exact, such risk adjustment of the money received by the insurer would help change the present incentive from just enrolling healthy people to an incentive to concentrate on the most efficient way to take care of the sick. Standardized policies and full disclosure could shift the incentive from marketing to administrative efficiency.

    Other distorted incentives include more concern about current than about long-term insurance costs as well as an emphasis on full payment for high-cost hospitalization. These lead to high front-end deductibles that do not deter hospitalization but do limit economical coverage of prevention and early illness care, services that could actually reduce hospitalization.14,30,41

  6. Underfunded and confused Medicaid programs:

    Low-income people on Medicaid are faced with multiple regulations from state programs dictated by 50 different legislatures with hundreds of different pressure groups shaping benefits packages. Parsimonious medical and social funds are mixed, obfuscating the costs of both. Medicaid should be bifurcated leaving the social costs to the states and medical costs to the federal government. FHIRS basic benefit package would be used to bring this group into the mainstream of medical practice with costs subsidized or in some cases paid for with tax credits.

  7. The Ponzi-type Medicare scam of cross-generational financing:

    When established, ∼13 working people were taxed to pay for every Medicare recipient. The ratio is now 3:4 workers per recipient and will become worse, creating a financial disaster for both the elderly and the taxpayers. Medicare as we know it is unsustainable.22 The problem is compounded by political pressure to increase benefits, some for unproven and ineffective services. FHIRS should define the benefits package and the financing mechanism should be changed for future recipients to a forced-savings program as proposed by Senator Gramm.31 FHIRS regulations and incentives could replace the current biblical compendium of rigid Medicare regulations.

  8. Insufficient national clinical trials and lack of constraint of malpractice lawsuits:

    New modalities of treatment are sometimes mandated long before they are proven, increasing costs, frustrations, and suffering.11,13 Likewise, obsolete methods of treatment are not excluded from benefit packages because of pressure groups within various provider communities or plaintiff-induced suits fostered by the trial bar. For example, nearly every insurer was forced to cover autologous bone marrow replacement in patients with stage IV breast cancer, although it was later shown to be ineffective.32,33 The total problem of the cost of litigation and defensive medicine creates a gigantic drain on the public that ultimately pays through taxes or private insurance.24

    Objective national clinical trials encouraged by FHIRS, in cooperation with the NHI, the Institute of Medicine and academia, with a small percentage of insurance premiums for funding, will enable FHIRS to develop sound benefits packages that could dampen the effects of lawsuits over benefits and some treatment modalities. This, plus required disclosure, could suppress the rising number of class action suits and frivolous litigation. Basic tort reform is essential.

  9. Unfair competition by hospitals charging their own patients different amounts for identical services and pharmaceutical companies charging individuals and small organizations more than large organizations, increasing the number of uninsured:

    In the past hospitals charged the affluent more than others so they could afford to treat the poor. Overcharging of some is now used commercially to take advantage of insurance payment and discounting, so one neighbor with insurance X pays a far greater amount than neighbor with insurance Y for the same service. This practice, obscured as a trade secret in competitive bidding, is actually anticompetitive in that it does not provide the individual a choice based on cost or perceived quality, but instead gives the insurer of large groups the biggest discounts. This increases costs to small groups and individuals contributing to the rise in the uninsured. A fair trade system for FHIRS tax-advantaged insurance would allow hospitals to compete against each other on the basis of quality and cost so patients can decide whether it is worthwhile to pay more to go to a more expensive hospital for perceived quality benefits.

    A similar type of problem inequitably increases the costs for individuals and small organizations purchasing pharmaceuticals. To “get the business,” steep discounts are given to medical groups and insurers to encourage use of a particular brand of medication. Aside from the lack of an overall assessment of the medical and cost-effectiveness of one brand versus another, an issue that also requires correction, this unfair variety of competition is in reality also anticompetitive. The use of a particular medication should depend on its basic value and competitive cost rather than unfair discounting.

  10. Excessive costs threaten the national economy, access to quality medical services, and federal and state budgets partly because of the lack of economic incentives to limit health care expenditures:

    Under the FHIRS proposal, to cover subsidy, tax credits, and loss of income from tax-free insurance, Congress would establish a budget. FHIRS would have several options including altering the benefits packages, increasing copayments, and/or reducing the upper limits of tax-advantaged fees to stay within that budget without Congressional interference. The first priority of the FHIRS would be to protect basic health financing for the entire population. A high percentage of medical costs result from often heroic and unproven treatment of basically terminal illnesses, followed by a limited poor quality life. Priorities will ultimately need to be set by an impartial body such as the FHIRS.

    Other steps to control costs would be ongoing, regardless of budgetary constraints. The FHIRS would use many tools:

  11. Altering the benefits packages to drop minimally effective services could reduce ultimate costs.

  12. Objectively developed adjustments of copayment can be a valuable tool to encourage proven preventive services and discourage less valuable services, reducing ultimate costs.14,34–37

  13. The FHIRS would have the power to establish geographic upper limits of tax advantage to keep within the budgetary constraints of Congress but would not be able to limit providers from charging more if the individual purchaser was clearly notified when buying the policy of provider charges that would be above the tax-advantaged limits. Competition between providers for patients could tend to suppress escalating costs.

  14. As information develops, the FHIRS could track administrative costs and profits of insurers, and publish them if warranted. However, competition will keep administrative expenses down, and under FHIRS incentives will replace many costly regulations. Marketing costs will be significantly reduced by FHIRS standard policies with fully informed purchasers aware of benefits and premiums. Policies will be available through employers and public facilities so brokers and their nearly 5% fees will be unneeded.20

  15. Working spouses under employer-purchased insurance often have duplicate insurance coverage, creating the expense of coordination of benefits that would be eliminated by individual and family purchase of policies.

  16. Automatic premium collection through the existing quarterly federal income tax mechanism will reduce some administrative costs.

  17. Insurers could contract with providers to offer lower-priced policies to the public by various innovative methods of delivery of care.

  18. The FHIRS and insurers could track and analyze utilization patterns, charges and costs of physicians, hospitals, and individuals and use the confidential findings educationally to improve cost-effectiveness and prudent utilization.

  19. Encouraging personal patient/physician continuity of care by reducing employer-forced changes of physicians will:

    1. Reduce the costs of transfer of medical records and the increased cost of new patient services versus established patient services.

    2. Reduce fragmentation and duplication of care by establishing a medical home that can also reduce expensive emergency department use and hospitalization.38–42

    3. Increase the personal physician’s knowledge of the patient with resulting greater efficiency in care, patient satisfaction, and compliance.43

  20. Reducing defensive medicine and malpractice lawsuits:

    1. FHIRS-designed tax-advantaged coverage would be protected from lawsuits about coverage.

    2. Full patient previous knowledge of physician accessibility in a plan would reduce suits about choice of physicians.

    3. Data collection and analysis can result in more realistic community standards of practice and outcome, reducing defensive medicine.

    4. Full tort reform should accompany any finance reform.

  21. Lack of a national program to coordinate, analyze, and recommend optimizing medical care and controlling costs:

    Even under the present crippled financial systems, medical progress continues. However, some of these efforts receive more attention for their newness than how they affect cost, access, and ultimate outcome. An organized approach to coordinate, encourage, and finance efforts to carefully assess the overall effects of both new and traditional medical modalities can be quite helpful.

    FHIRS, as an apolitical agency free from commercial pressures, would be in an ideal position to lead and encourage such efforts. The large computer capability necessary for other aspects of FHIRS operations could be used to collect insurer’s data, hospital outcome data, and longitudinal data on chronic conditions and costs. Used with assured patient confidentiality, they could be shared with various private and government research institutions, academia, and organized medicine.

DISCUSSION

The number of uninsured demonstrates a partial failure of our medical system. Many recognize the necessity for compulsory catastrophic coverage for all residents. In addition, a more comprehensive basic coverage is justified for children who cannot make economic choices for themselves. The problem is how to achieve this in a system that can maintain economic viability while meeting the basic health needs of both individuals and society. Among the basic flaws in the current system that reduce viability is limited individual freedom of choice of care with lack of perceived individual responsibility for the cost of that care. Neither the current market-driven nor the single-payer government systems have managed to solve these problems. Our proposed FHIRS is the linchpin necessary to correct these problems by reforming the current market-driven system and avoiding the difficulties of single-payer government programs.

Eliminating employer selection of health insurance for their employees enhances individual freedom and responsibility. Insurers would clearly disclose all aspects of their offerings and the percent that qualifies for favorable tax treatment to enable choice based on benefits, provider availability (including how the providers are paid), and the tax consequences to the individual. Providing individuals with reverse-to-income tax credits and allowing those without employer-defined contributions the same tax advantage improves tax system fairness.

Ultimately, in the proposed system, its fiscal integrity would rest on the amount Congress is willing to subsidize directly and forgo in tax-related income, buttressed by the freedom of individuals to purchase taxable services as most do now, for example, when paying for unproven alternative medicine.5 A FHIRS is essential to objectively decide, on a scientific basis, which benefits under the Congressional fiscal limits are included in subsidies or tax-advantaged policies. If fiscal integrity is to be maintained, with medical science poised as it is to take quantum steps forward, it is essential that a body such as the FHIRS decide on the advantaged benefits rather than lobbyists or the trial bar with their threats of huge class action lawsuits. Also, it is essential to protect Medicare from the fiscal quicksand it stands on. The FHIRS, by being able to adjust coverage, maximum tax-advantaged charges, and copayments can modulate utilization and costs to keep within the Congressional tax budget. Allowing providers to charge above the tax advantaged limits, with prior patient knowledge, enables patients and providers to agree or compromise on the personal value of services.

A risk adjustment index for each policy based on the risks of individual enrollees can shift the incentives of insurers away from just seeking healthy enrollees to one with more emphasis on prevention and effective efficient care of the sick. Requiring an all-payer system for hospitals and pharmaceuticals would further enhance fair and innovative competition. FHIRS stimulation of national clinical trials can lead to improved community standards of practice, medical efficiency, and better patient outcomes. Protecting FHIRS-designed policies from lawsuits over coverage, and the development of scientifically-based community standards of care could reduce expensive litigation. FHIRS also has tremendous potential for tracking longitudinal outcome data, sharing it with medical organizations, academia, and the Institute of Medicine to develop improved practice procedures and outcomes.

Because FHIRS would develop the benefit packages, including those of Medicare and Medicaid, they would be designed to be compatible with funding. This would be a marked contrast to the present situation in which political bodies mandate benefits but underfund them, thus requiring administrators to squeeze benefits into inadequate funding. The resulting biblical-sized regulations requiring provider compliance create significant administrative expense and may occasionally limit care inappropriately.

The FHIRS would pragmatically merge the independent free market of health care financing with necessary oversight under a policy that will allow flexibility, innovation, and productive competition progressing toward efficient health care while increasing individual freedom of choice and reducing provider shackles. It would correct the market system’s transgressions, establishing a basis for fair competition. Regardless of the system adopted, whether it is some form of NHI, single-payer or our proposed market-driven system, a FHIRS organization will be needed to rationally design and prioritize benefits, leading to fiscally sound systems and prudent use of resources.

Can we get there from here? The current system is hemorrhaging funds and a tourniquet is needed, making it rational to anticipate that a sweeping reform can be achieved, even in the face of the powerful entrenched players involved. Band-Aids won’t work. The temptation will be to temporarily patch the current system rather than do what is really required—basically reform the system from the ground up. America does respond to crisis so we anticipate that by calling attention to some of the underlying causes crippling the medical care system, articles such as this will increase awareness that reasonable reform is possible. There may be a FHIRS in our future!

Footnotes

    • Received December 23, 2002.
    • Accepted January 28, 2003.
  • Reprint requests to (G.E.A.) 10506 SW Forest Ridge Place, Beaverton OR 97007. E-mail gamd{at}easystreet.com
FHIRS, Federal Health Insurance Reserve System, NHI, National Health Insurance

REFERENCES

  1. ↵
    Iglehart JK. The American health care system: expenditures. N Engl J Med.1999;340 :70– 76
    OpenUrlCrossRefPubMed
  2. ↵
    New York Academy of Sciences. Medical Education and Clinical Research in the 21st Century: Special Report. New York, NY: New York Academy of Sciences; 2000:1–14
  3. Health Policy Group, Division of Social Economic Policy Development, AMA. Expanding Health Insurance, AMA Proposal for Reform. Chicago, IL: American Medical Association; 2002
  4. ↵
    Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: Institute of Medicine, Committee on Quality of Health Care in America; 2001
  5. ↵
    Brodenheimer T. The American health care system—physicians and the changing medical marketplace. N Engl J Med.1999;340 :584– 588
    OpenUrlCrossRefPubMed
  6. Riley B. Torch Those Managed Care Contracts? Montvale, NJ: Medical Economics (Pediatrics); 2001:30–36
  7. ↵
    Pear R. States are facing big fiscal crisis, governors report. New York Times. November 26, 2002:314
  8. ↵
    Krugan P. Bad medicine. New York Times. March 19, 2002:A27
  9. ↵
    Krauz C. Canada’s health care system needs more cash, panel says. New York Times. November 29, 2002:A12
  10. ↵
    Jensen GA, Morrisy MA. Mandated Benefit Laws and Employer Purchased Health Insurance. Health Insurance Association of America Statement. Washington, DC: Health Insurance Association of America; 1999
  11. ↵
    Perez-Pena VH. Passing a health measure without a second thought. New York Times. January 13, 2002:A27
  12. ↵
    Health Insurance Association of America. Issue Brief: Why Do Health Insurance Premiums Rise? Washington, DC: Health Insurance Association of America; 2000:1–21
  13. ↵
    Kuttner R. The American health care system: Wall Street and health care. N Engl J Med.1999;340 :664– 668
    OpenUrlCrossRefPubMed
  14. ↵
    Austin G. Child health-care financing and competition. N Engl J Med.1984;311 :1117– 1120
    OpenUrlPubMed
  15. Newhouse JP, Manning WG, Morris CN, et al. Some interim results from a controlled trial of cost sharing in health insurance. N Engl J Med.1981;305 :1501– 1507
    OpenUrlCrossRefPubMed
  16. Rosenbaum S, Frankford DM, Moore B, Borzi P. Who should determine when health care is medically necessary? N Engl J Med.1999;340 :229– 232
    OpenUrlCrossRefPubMed
  17. ↵
    Brumbach K, Osmond D, Vranizan K, Jaffe D, Bindman AB. Primary care physicians’ experience of financial incentives in managed-care systems. N Engl J Med.1998;339 :1516– 1521
    OpenUrlCrossRefPubMed
  18. ↵
    American Academy of Pediatrics, Committee on Child Health Financing. Medicaid policy statement. Pediatrics.1999;104 ;344– 347
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Mccabe, T. HCFA mess a hurdle for Thompson. The Medical Herald. February2001:1– 5
  20. ↵
    Medicare Payment Advisory Commission. Report to the Congress: Medical Savings Accounts and the Medicare Program. Medicare Payment Advisory Commission; 2000:1–25
  21. Ginsberg E. The uncertain future of managed care. N Engl J Med.1999;340 :144– 146
    OpenUrlCrossRefPubMed
  22. ↵
    Saving TR, Gramm P. Medicare policy for future generations—a search for a permanent solution. N Engl J Med.1998;338 :1307– 1311
    OpenUrlCrossRefPubMed
  23. ↵
    Brodenheimer T. The American health care system: the movement for improved quality in health care. N Engl J Med.1999;340 :448– 492
    OpenUrlCrossRefPubMed
  24. ↵
    Studdert DM, Brennan TA. The problems with punitive damages in lawsuits against managed-care organizations. N Engl J Med.2000;342 :280– 284
    OpenUrlCrossRefPubMed
  25. ↵
    Horn SD. A Plan to Modify DRGs. Business and Health. The Washington Business Group on Health. Washington, DC: Thomas Publishing Group; 1985:32–35
  26. Iezzoni LI, Ayanian JZ, Bates DW, Burstin HR. Paying more fairly for Medicare capitated care. N Engl J Med.1998;339 :1933– 1938
    OpenUrlCrossRefPubMed
  27. Blumberg MS, Iezzoni LI. Risk Adjustment for Medicare. N Engl J Med.1999;340 :1514– 1515
    OpenUrlCrossRefPubMed
  28. Glazer J, McGuire TG. Why don’t private employers use risk adjustment? Conference overview. Inquiry.2001(Fall);38 :342– 244
    OpenUrl
  29. ↵
    Keenan PS, Buntin MJ, McGuire TG, Newhouse JP. The prevalence of formal risk adjustment in health plan purchasing. Inquiry.2001(Fall);38 :242– 244
    OpenUrlPubMed
  30. ↵
    Austin GE. Consistent Preventive Care Can Lead to Payoff. Business and Health. Washington Business Group on Health. Washington, DC: Thomas Publishing Group; 1985:10–13
  31. ↵
    Frankel G, Thompson RE, Gramm P, Rettenmaier AJ, Saving TR. Reforming Medicare: The Gramm Plan. N Engl J Med.1998;339 :777– 778
    OpenUrlCrossRefPubMed
  32. ↵
    Thomas ED. Does bone marrow transplantation confer a normal life span? N Engl J Med.1999;341 :50– 51
    OpenUrlCrossRefPubMed
  33. ↵
    Welch HG. Presumed benefits: lessons from the American experience with marrow transplantation for breast cancer. BMJ.2002;324 :1088– 1092
    OpenUrlFREE Full Text
  34. ↵
    Solanki G, Schauffler HH. Cost-sharing and the utilization of clinical preventive services. Am J Prevent Med.1999;17 :127– 133
    OpenUrlCrossRefPubMed
  35. Solanki G, Schauffler, HH, Miller LS. The direct and indirect effects of cost-sharing on the use of preventive services. Health Serv Res.2000;34 :1331– 1350
    OpenUrlPubMed
  36. Health Insurance Association of America. Statement: Concerns About the Theory of Increased Cost-Sharing on Beneficiaries and Its Policy Implications for the Medicare Program. Health Insurance Association of America; 2001:1–3
  37. ↵
    Newhouse JP, The Insurance Experiment Group. Free for All? Cambridge MA: Harvard University Press; 1993
  38. ↵
    Christakis DA, Wright JA, Koepsell D, Emerson S, Connell FA. Is greater continuity of care associated with less emergency department utilization? Pediatrics.1999;103 :738– 742
    OpenUrlAbstract/FREE Full Text
  39. Weiss LJ, Bluestein J. Faithful patients: the effect of long-term physician-patient relationships on the cost and use of health care by older Americans. Am J Public Health.1998;88 :135– 136
    OpenUrlCrossRefPubMed
  40. Raddish M, Horn SD, Sharkey PD. Continuity of care: is it cost effective? Am J Managed Care.1999;5 :727– 733
    OpenUrlPubMed
  41. ↵
    Kozak LJ, Hall MJ, Owings M. Trends in avoidable hospitalizations, 1980–1998. Health Aff. March/April2001:225– 232
  42. ↵
    Newacheck PW, Stoddard JJ, Hughes, DC, Pearl M. Health insurance and access to primary care for children. N Engl J Med.1998;338 :513– 519
    OpenUrlCrossRefPubMed
  43. ↵
    Starfield B. Primary Care: Balancing Health Needs, Services and Technology. New York, NY, and Oxford, United Kingdom: Oxford University Press; 1998:143–168
  • Copyright © 2003 by the American Academy of Pediatrics
PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 111, Issue 5
1 May 2003
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An Innovative Proposal for the Health Care Financing System of the United States
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
An Innovative Proposal for the Health Care Financing System of the United States
Glenn E. Austin, Robert D. Burnett
Pediatrics May 2003, 111 (5) 1093-1097; DOI: 10.1542/peds.111.5.1093

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
An Innovative Proposal for the Health Care Financing System of the United States
Glenn E. Austin, Robert D. Burnett
Pediatrics May 2003, 111 (5) 1093-1097; DOI: 10.1542/peds.111.5.1093
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • PROBLEMS REQUIRING SOLUTIONS
    • HOW THE FHIRS PROPOSAL WOULD AMELIORATE THESE PROBLEMS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Association Between Underinsurance and Access to Care Among Children With Special Health Care Needs in the United States
  • Four AAP Fellows elected to AMA leadership posts
  • Google Scholar

More in this TOC Section

  • Enrolling Minors in COVID-19 Vaccine Trials
  • Perspectives on Race and Medicine in the NICU
  • Islamic Beliefs About Milk Kinship and Donor Human Milk in the United States
Show more Special Articles

Similar Articles

Subjects

  • Advocacy
    • Child Health Financing
    • Advocacy

Keywords

  • FHIRS, Federal Health Insurance Reserve System
  • NHI, National Health Insurance
  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics